Thymosin Beta-4 fragment

TB-500

Grade CConsistent animal data; no injectable human trials; WADA-banned

A synthetic fragment of the natural healing protein thymosin beta-4 — solid animal evidence, no controlled human data on the injected form, and a firm WADA ban.

✦ 2 min read · 2 sources

What it is

TB-500 is a synthetic 7-amino-acid peptide copying the active actin-binding region of thymosin beta-4 (TΒ4), a protein found in nearly every human cell and released at wound sites. It is a fragment/analog, not the full natural protein, and is not FDA-approved.

How it works

TΒ4 binds G-actin, a building block of the cell's internal scaffolding. By regulating actin, TB-500 is thought to help cells reorganize and migrate to an injury — an early step in healing — with proposed downstream angiogenesis, reduced inflammation, and tissue regeneration.

What the evidence shows

Animal and cell research consistently supports a role for thymosin beta-4 in skin, corneal, cardiac, tendon, and muscle repair, replicated by independent labs. The crucial caveat: the best human data come from full-length TΒ4 in a topical eye-drop, not the injected TB-500 fragment athletes use. There are essentially no rigorous human trials of injected TB-500 for sports injuries.

Quick check

Test what you just read

Four questions, ~60 seconds, with a sourced result.

The honest take

Consistent animal data; no injectable human trials; WADA-banned

Status & safety

Not FDA-approved for this use. TB-500 / thymosin beta-4 derivatives are named on the WADA Prohibited List under S2 (peptide hormones, growth factors), banned at all times. Purity is a real concern with research-only suppliers.

Summaries of published, third-party research for educational purposes. Not medical advice; not a claim of efficacy or safety for any use.

Stay current on the research

New, plain-language summaries as the literature develops. Educational only — no products, nothing for sale.

More in this series